title: Recent advances in the management of Duchenne muscular dystrophy.
abstract: Duchenne muscular dystrophy (DMD) is the commonest inherited neuromuscular disorder of childhood and mainly affects males. Over the course of the last century, the average life expectancy of these patients has doubled and now stands at ∼25 years. This progress has been made possible through advances in the diagnosis, treatment and long-term care of patients with DMD. Basic and clinical research, national and international scientific networks, and parent and patient support groups have all contributed to achieving this goal. The advent of molecular genetic therapies and personalised medicine has opened up new avenues and raised hopes that one day a cure for this debilitating orphan disease will be found. The main purpose of this short review is to enable paediatricians to have informed discussions with parents of boys with DMD about recent scientific advances affecting their child's clinical care.
authors.affiliation: The John Walton Muscular Dystrophy Research Centre, Newcastle upon Tyne, UK.
authors.forename: Eugen-Matthias
authors.initials: EM
authors.lastname: Strehle
authors.affiliation: The John Walton Muscular Dystrophy Research Centre, Newcastle upon Tyne, UK.
authors.forename: Volker
authors.initials: V
authors.lastname: Straub
mesh_terms: D002648:Child; D019468:Disease Management; D006801:Humans; D008134:Long-Term Care / Q000379:methods*; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000175:diagnosis / Q000628:therapy*; D010290:Parents
keywords: Neuromuscular; Outcomes research; Pharmacology; Statistics; Technology